XERAYA CAPITAL
Xeraya Capital is a private equity and venture capital firm.
XERAYA CAPITAL
Industry:
Financial Services
Founded:
2012-01-01
Status:
Active
Contact:
+60323818700
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Mobile Non Scaleable Content Google Apps For Business
Similar Organizations
Castle Island Ventures
Castle Island Ventures is a venture capital firm,
Current Employees Featured
Fares Zahir CEO & Co-Founder @ Xeraya Capital
CEO & Co-Founder
2012-01-01
Jason Rushton Investments Partner @ Xeraya Capital
Investments Partner
Bruce Cohen Venture Partner @ Xeraya Capital
Venture Partner
2016-01-01
James Tee Vice President - Investments @ Xeraya Capital
Vice President - Investments
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-03 | Greenlight Biosciences | Xeraya Capital investment in Post-IPO Equity - Greenlight Biosciences | 125.5 M USD |
| 2021-12-09 | OncoMyx Therapeutics | Xeraya Capital investment in Series B - OncoMyx Therapeutics | 50 M USD |
| 2021-12-08 | Viron Inc. | Xeraya Capital investment in Series B - Viron Inc. | 50 M USD |
| 2020-11-19 | Imago BioSciences | Xeraya Capital investment in Series C - Imago BioSciences | 80 M USD |
| 2020-11-16 | InterVenn | Xeraya Capital investment in Series B - InterVenn | 34 M USD |
| 2020-11-09 | Congenica | Xeraya Capital investment in Series C - Congenica | 50 M USD |
| 2020-05-20 | Rapid Micro Biosystems | Xeraya Capital investment in Private Equity Round - Rapid Micro Biosystems | 120 M USD |
| 2020-05-12 | Greenlight Biosciences | Xeraya Capital investment in Venture Round - Greenlight Biosciences | 17 M USD |
| 2020-02-25 | Aria CV | Xeraya Capital investment in Series B - Aria CV | 31 M USD |
| 2020-01-29 | P2 Science | Xeraya Capital investment in Series C - P2 Science | 12 M USD |
More informations about "Xeraya Capital"
Xeraya Capital | Life Ventures
Feb 29, 2024 Get In Touch Xeraya Capital Sdn Bhd 26.03–26.08, G Tower #199 Jalan Tun Razak, KL xeraya@xeraya.com +603 2381 8700See details»
Xeraya Capital - Crunchbase Investor Profile
Legal Name Xeraya Capital Sdn. Bhd. Investor Type Private Equity Firm, Venture Capital Investment Stage Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity Number of Exits . obfuscated. obfuscated. Phone Number …See details»
Board of Directors - Xeraya Capital
Get In Touch Xeraya Capital Sdn Bhd 26.03–26.08, G Tower #199 Jalan Tun Razak, KL xeraya@xeraya.com +603 2381 8700See details»
Xeraya Capital - Investments, Portfolio & Company Exits
Xeraya Capital 's most notable exits include Greenlight Biosciences, Acutus Medical, and Gevo. Which industries has this organization had the most exits in? Show . Greenlight Biosciences …See details»
Xeraya Capital - LinkedIn
Xeraya Capital | 3,133 followers on LinkedIn. Life Venture | Investing towards the betterment of humanity. At Xeraya, all of our activities, expertise, and resources focus solely on the Life ...See details»
Xeraya Capital | Malaysia #1 source for Business Funding
Xeraya Capital invests in the life sciences globally, seeking significant minority equity positions in privately held companies. By combining financial resources, industry expertise, and a global …See details»
Xeraya Capital - AVPN
AVPN is proud to be a CAF International Validated Organization. This badge reflects our commitment to transparency, accountability, and the highest standards of nonprofit operations. ... Investment Operations & Special …See details»
Xeraya Capital - Investor Profile, Portfolio & Team - Tracxn
Mar 25, 2025 Xeraya Capital-backed InterVenn Biosciences raises $34m in Series B roundDeal Street Asia • Nov 19, 2020 • Xeraya Capital, InterVenn InterVenn Biosciences Raises $34M to …See details»
Xeraya Capital - Funding, Financials, Valuation & Investors
Xeraya Capital has raised a single venture fund, Xeraya Opportunity Fund. Funds Raised. Edit Funds Raised Section. Number of Funds 1. Xeraya Capital has raised a single venture fund, …See details»
Xeraya Capital investment portfolio - PitchBook
Xeraya Capital's latest investment was on 18-Jul-2022 in Aria CV, a company within the Therapeutic Devices industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most …See details»
Our Focus - Xeraya Capital
Xeraya Capital Sdn Bhd 26.03–26.08, G Tower #199 Jalan Tun Razak, KL xeraya@xeraya.com +603 2381 8700 Submit a Proposal proposal@xeraya.com Back . Our Focus. What We Do at …See details»
Xeraya Capital - Private Equity List
Xeraya Capital. Investor type. VC. Founded. 2012. AUM-Location. Malaysia. $1-5 m. Investment Ticket. Long-term. Investment Horizon. Series A Investment Stage. IPO Exit Strategy. Profile. …See details»
Xeraya Capital - CB Insights
Feb 3, 2022 Xeraya Capital focuses its activities, expertise, and resources focus solely on the Life Sciences sector. The firm looks to generate superior investment returns by cultivating …See details»
Xeraya Capital | Institution Profile - Private Equity International
Xeraya Capital contact information Offices 26.03 – 26.08 Level 26, G Tower, 199 Jalan Tun Razak, Kuala Lumpur, 50400, Malaysia Showing 1 of 1 Xeraya Capital officesSee details»
XERAYA CAPITAL SDN. BHD. (Malaysia) - CTOS One Off Report
XERAYA CAPITAL SDN. BHD. was incorporated on 2004-08-27 in Malaysia with registration number of 0664217M / 200401025709. XERAYA CAPITAL SDN. BHD.'s business includes …See details»
Xeraya Capital – Investors Database – Unicorn Nest
The high activity for fund was in 2016. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Xeraya Capital works on …See details»
Xeraya Capital - Contacts, Employees, Board Members
Xeraya Capital is a private equity and venture capital firm.See details»
Khazanah-backed Xeraya Capital seeks $400m for fourth life …
Feb 4, 2020 Malaysia-based life sciences-focused investment firm Xeraya Capital is seeking to raise $400 million for its fourth fund, its CEO Fares Zahir told DealStreetAsia. The new fund, …See details»
Mr. Amirul Fares Wan Zahir - KSI Strategic Institute for Asia Pacific
MR. FARES ZAHIR was appointed Chief Executive Officer (CEO)of Xeraya Capital Sdn Bhd in January 2012, he has around 30 years of experience in the field of investment in public and …See details»
Trump Organization sues Capital One for closing its bank accounts …
Mar 7, 2025 President Donald Trump’s business trust sued Capital One for closing its bank accounts in 2021, claiming the North Carolina lender “debanked” them over their political …See details»